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Abstract
Rationale—Severity of tissue injury in occlusive disease is dependent on the extent (number and
diameter) of collateral vessels, which varies widely among healthy mice and humans. However,
the causative genetic elements are unknown. Recently, much of the variation among different
mouse strains, including C57Bl/6J (B6, high extent) and BALB/cByJ (Bc, low), was linked to a
QTL on chromosome 7 (Candq1).
Objective—We used congenic mapping to refine Candq1 and its candidate genes and create an
“isogenic” strain-set with large differences in collateral extent to assess their and Candq1’s
impact, alone, on ischemic injury.
Methods and Results—Six congenic strains possessing portions of Candq1 introgressed from
B6 into Bc were generated and phenotyped. Candq1 was refined from 27 to 0.737 Mb with full
retention of effect, ie, return/rescue of phenotypes from the poor values in Bc to nearly those of
wildtype B6 in the B6/B6 congenic mice: 83% rescue of low pial collateral extent, and 4.5-fold
increase in blood flow and 85% reduction of infarct volume after middle cerebral artery occlusion;
54% rescue of low skeletal muscle collaterals, and augmented recovery of perfusion (83%) and
function after femoral artery ligation. Gene deletion and in-silico analysis further delineated the
candidate genes.
Conclusion—We have significantly refined Candq1 (now designated Determinant of collateral
extent-1, Dce1), demonstrated that genetic background-dependent variation in collaterals is a
major factor underlying differences in ischemic tissue injury, and generated a congenic strain-set
with wide, allele-dose-dependent variation in collateral extent for use in investigations of the
collateral circulation.
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Cerebral vascular disease, stroke, coronary artery disease (CAD), peripheral artery disease
(PAD) and other obstructive arterial diseases are the leading cause of morbidity and
mortality worldwide.1 The extent (number and diameter) of native (pre-existing) collaterals,
a unique type of blood vessel within the microcirculation of most tissues, plays a major role
in reducing the severity of ischemic tissue injury and cell death. Collaterals are arteriole-to-
arteriole anastomoses that cross-connect a small percentage of the outer branches of adjacent
arterial trees.2,3 When the trunk of one of the trees becomes obstructed, collateral flow from
the adjacent tree provides retrograde perfusion of the occluded tree. Even a modest amount
of collateral flow can significantly decrease tissue injury after acute obstruction. Moreover,
chronic obstruction induces collaterals to increase their anatomic lumen diameter, ie,
remodel, by as much as 10-fold over days-to weeks, depending on the tissue and species.
Collateral remodeling (arteriogenesis), which is stimulated by fluid shear stress, is capable
of further greatly increasing collateral flow, depending on the extent of the native collaterals
in the affected tissue and vigor of the molecular mechanisms that drive the remodeling
process.
It is well known among stroke and neurovascular specialists, interventional cardiologists and
vascular surgeons that tissue ischemia and infarction vary greatly among patients despite
similar sites and severity of acute or chronic arterial obstruction. The mechanisms
responsible for this variation remain ill-defined. Recent studies have reported wide variation
among “healthy” individuals (ie, without obstructive disease in the tissue under
examination) in the amount of blood flow provided by the native collateral circulation. In
individuals without angiographically detectable CAD, ie, free of collateral remodeling that
could differ and prevent interpretation of such measurements vis-à-vis native collateral
extent, collateral flow index (CFI) was distributed normally and varied by ~10-fold, with
20% of individuals having low CFIs.4 Importantly, patients with CAD and poor collateral
flows had a 64% higher risk of mortality.5 CFI also varied significantly in the lower
extremities of individuals without PAD.6 And similarly, in patients with sudden thrombo-
embolic occlusion of the middle cerebral artery (MCA) (the most common cause of
ischemic stroke), retrograde perfusion of the MCA tree—as assessed by neuroimaging
during the hyper-acute phase of stroke—varied widely, with 20% having poor pial collateral
scores.7–11 Notably, such individuals sustain significantly larger infarct volumes, respond
poorly to thrombolytic treatments, have increased risk for and severity of cerebral
hemorrhage, and suffer increased morbidity and mortality.7–14 Thus, collateral score is
increasingly being viewed as important diagnostic measurement to identify the optimal
course of treatment and assess prognosis for recovery.12–14
Nothing is known about the genetic and little about the environmental15–17 mechanisms that
are responsible for the wide variation in native collateral-dependent flow in humans.
However, recent studies in mice have found that genetic background is a major factor. In the
brain, pial collateral number and diameter varied by 35-fold and 4-fold, respectively, among
21 inbred strains.18,19 Collateral number and diameter were highly heritable, positively
correlated, and independent of potentially confounding variables (cerebral artery tree area,
cortical area, body weight). Similarly wide variation in collateral extent was seen in other
tissues of a subset of these strains, including hindlimb skeletal muscle.20,21 A genome-wide
linkage analysis of an F2 cross between two strains at the extremes of the distribution for
pial collateral number, C57Bl/6J (B6) and BALB/cByJ (Bc), yielded a single QTL on
chromosome 7 (LOD 30, 127–140 Mb; MGSCv37 mm9) for both number and diameter
(Canq1, here renamed Candq1).22 Candq1 accounted for the majority of the variance,
whereas weaker QTLs were also found for collateral number on chromosomes 1, 3 and 8.22
SNP-mapping of Candq1 among the 21 strains using the Efficient Mixed Model Algorithm
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(EMMA)23 suggested a much narrower locus (132.36–132.82 Mb) and a 9-member
candidate gene list.19 Candq1 was also linked to variation in collateral remodeling through
its linkage to variation in native collateral diameter18,22—which is well-known to be the
major determinant of the strength of the shear-stress stimulus that drives collateral
remodeling.3
Interestingly, Candq1 is identical in peak marker location to QTLs found earlier in B6 and
Bc mice for recovery of hindlimb perfusion and tissue necrosis 21 days after femoral artery
ligation (FAL) (LSq-1)24 and for infarct volume 24 hours after permanent MCAO (Civq1).25
Based on haplotype analysis of LSq-1, a list of 37 potential candidate genes was obtained,24
while a refined haplotype analysis of Civq1 gave a partially overlapping list of 12
candidates.25 Neither list overlapped with the candidate genes derived from EMMA
mapping for collateral number and diameter.19 Moreover, the distribution of infarct volumes
across 15 strains25 was closely predicted by the strain-specific values for collateral number,
diameter, and length, plus hematocrit and MCA tree territory.18 Similarly, values for blood
flow, hindlimb use and ischemic appearance immediately after and 21 days after FAL of B6,
Bc and an F1 cross correlated with the high (B6), low (Bc), and intermediate (F1) number of
collaterals in the adductor thigh region and cerebral cortex of these strains.21 This suggests
that genetic variation in native collateral extent is the major physiological substrate
responsible for the variation in blood flow and tissue injury in brain and hindlimb following
arterial obstruction and for the three coincident QTLs on chromosome 7.19,22
Taken together, the above studies present a significant conundrum. They propose 3 different
candidate gene lists for a single phenomenon. Although there is strong evidence18–22 that
variation in the extent of the native collateral circulation is a major factor underlying
variation in the above ischemic injury traits—including the conclusion that Candq1 and
Civq1 may be one and the same18–22,26—differential metabolic sensitivity of cells to
hypoxia/ischemia has recently been proposed to be a significant determinant of the variation
in response to ischemia conferred by Candq1 and Lsq-1.26 This hypothesis would suggest
that the three coincident QTL cover multiple processes, the loci for which would
presumably cease to overlap with dissection of Candq1 into smaller regions. To address the
above uncertainties, we constructed a series of congenic mouse strains in which sub-regions
of Candq1 from B6 were introgressed into the Bc genome, and used them to examine 3
aims: 1) To establish the most cogent gene list possible to guide future investigation. 2) To
determine whether collateral extent, infarct volume following MCAO, and perfusion and
tissue injury following FAL continue to segregate together as the introgressed region
becomes smaller. Such a finding would strengthen the hypothesis that genetic-dependent
variation in collateral extent underlies the above QTL and is the major physiological factor
responsible for the differences in ischemic tissue injury in B6, Bc and related mouse strains.
3) To generate a congenic strain-set with wide differences in collateral extent for use in
future investigations of the collateral circulation.
METHODS
See online Data Supplement at http://circres.ahajournals.org for details.
Animals
Congenic strains were prepared by backcrossing B6-x-Bc recombinant inbred strains CXB3
and CXB427 to Bc, then successively backcrossing the progeny to Bc (~1500 mice bred and
genotyped). Cln3Δex7/8 mice28 and Cln3LacZ/LacZ (Δex1–8)29 (on B6 backgrounds) were
from Jackson Laboratories and Dr. Beverly Davidson, respectively. Mice engineered with
floxed alleles or made globally hypomorphic at Jmjd5 (Jmjd5Neo/+) (B6 background) were
from Dr. Takeshi Suzuki.30 Floxed mice were bred with B6-Cre mice to produce mice null
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for Jmjd5 in endothelial cells (Jmjd5ECΔ) or globally haploinsufficient (Jmjd5Δ/+). Gender
does not influence collateral extent in brain or hindlimb,18,21 thus cohorts were ~half male
and half female, and 2–4 mos-age. Approximately 2000 mice were bred, genotyped, and
phenotyped for this study.
Collateral number, diameter and remodeling
The vasculature was maximally dilated and filled with Microfil™ with viscosity adjusted to
minimize entrance into capillaries, followed by fixation and digital morphometry to obtain
baseline collateral number and diameter and collateral remodeling 3 days after MCAO.16
Since collaterals of the neocortex in mouse (and human) reside in the pia mater with none in
the brain parenchyma,31,32 their extent can be fully quantified using these methods.
Cerebral infarct volume
The right MCA trunk below the mid-temporalis muscle was permanently occluded
(MCAO).16 Brain slices were stained with 2,3,5-tripenyltetrazolium chloride (TTC) 24
hours later.
Cerebral blood flow
In separate mice, the vasculature was maximally dilated and PBS containing 6-micron
fluorescent microspheres and vasodilators was perfused retrograde via the thoracic aorta 24
hours after MCAO, followed by TTC staining of brain slices. Relative blood flow was
quantified as the number of trapped microspheres in the volume of infarcted brain,
normalized to the number trapped in the corresponding region/volume on the non-ligated
side.33–35
Hindlimb ischemia
Femoral artery ligation (FAL), laser Doppler measurement of plantar perfusion, which
correlates closely with overall hindlimb blood flow,36 and measurement of hindlimb use and
ischemic appearance were as described.20,21
Websites
See Online Table I for websites of databases used.
Statistics
Values are mean±SE. Data were tested with t-tests or ANOVA followed by Bonferroni post-
hoc tests (significance at p<0.05).
RESULTS
Construction of congenic strains
Congenic (CNG) strains were derived from two B6×Bc (CXB) inbred lines in which
homozygous blocks of B6 and Bc genotype are arranged in patchworks unique to each
line.27 CXB3 and CXB4 were chosen because they contained potentially advantageous
breakpoints within Candq1 near the EMMA region (Figure 1A). Congenic strains were
developed by repeated backcrossing of CXB3 and CXB4 mice and progeny to Bc. At each
round, congenic development was accelerated by screening progeny for loss of B6 genotype
outside of Candq1. This resulted in 6 CNG strains, in 5 of which the introgressed B6
genotype successively converges on the center of the 95% confidence interval of Candq1
(Figure 1A). In the exception, CNG1, the block of B6 ends at least 1 Mb centromeric to
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EMMA (Figure 1A). Strains CNG1, 2 and 6 were derived from CXB3; CNG3, 4, and 5 from
CXB4.
Since the CXB input lines are 55–60% Bc and we selected against B6 outside of Candq1
(see Online Methods), we began data collection at N5. To confirm that these mice were
essentially congenic, two N5 mice each from CNG5 and CNG6 were subjected to whole-
genome analysis using the megaMUGA chip (21,200 informative markers for B6 and Bcl;
FP de Villena, unpublished). Small blocks of B6 genome outside Candq1 were variously
found on chromosomes 5, 8, 11 and 14, but the percentages of B6 alleles among the
markers, most of them heterozygous, were <0.1%, 0.3%, 0.7%, and 2.1%, respectively. The
phenotyping results that were obtained with N5 and N6 mice (Figure 1C, discussed below)
were not different from preliminary phenotyping of N4 mice, confirming that this small
degree of “contamination” is without effect on collateral extent. Subsequently, in 3 N8
CNG5-B6/Bc mice, B6 alleles were found at only 19, 34 and 34 SNPs of the 21,213
informative SNPs outside Dce1.
Collateral number and diameter co-segregate and identify a single 737 kb locus
responsible for the large variability in collateral extent between B6 and Bc mice
The collateral traits—number and diameter—for wildtype Bc, CNG1-B6/B6 and CNGx-Bc/
Bc mice (x=2–6) were comparable (~1.0 collateral ~12 um in diameter; Figure 1C). Thus,
other genetic elements outside of Candq1 that contribute to the more numerous and larger
diameter collaterals that are present in wildtype B6 mice22 were eliminated from the
congenics by generation N5. CNG1 mice were not studied further.
The heterozygous (CNGx-B6/Bc) and homozygous (CNGx-B6/B6) genotypes conferred a
remarkably consistent allele-dose-dependent increase in collateral number and diameter onto
the Bc genome that is indistinguishable among the groups (P>0.7) (Figure 1C). The amount
of “rescue” of collateral number and diameter in CNG2–6 B6/B6 mice averaged 73±1% and
93±6%, respectively (83±4% for extent), of the wildtype B6 values. The residual differences
in collateral number between CNG3/5 B6/B6 and wildtype B6 presumably reflect the impact
of the 3 other small-effects QTL identified for collateral number in B6-x-Bc F2 mice.22 By
contrast, Candq1 was the only QTL identified for diameter in that study, which is consistent
with the greater rescue of diameter in the congenics. Importantly, both phenotypic traits
among CNG2–6 remained the same as the introgressed regions converged on the overlap
zone of CNG5 and CNG6, 133.229 – 133.966 Mb. Furthermore, they ceased to include the
EMMA region19,22 (Figure 1A; shown in detail in Online Figure I), indicating that this
region (present in CNG2–4 but not in CNG5 and 6) has no detectable effect. These data
suggest that the zone of overlap (0.737 Mb) contains the entire causal element of the
originally defined22 27 Mb QTL, Candq1, for both number and diameter. We designate this
region as Determinant of collateral extent 1 (Dce1, detailed map in Online Figure IB).
Differences in collateral extent specified by Dce1 account for the differences in severity of
tissue injury in mouse models of ischemic stroke and peripheral artery disease
Given their ~isogenic background outside of Dce1, the above congenic strains provide a
unique opportunity to determine the impact of differences in collateral extent, alone, on
tissue injury after arterial occlusion, free of the many other genetic-dependent hemodynamic
and molecular differences in B6 and Bc that could also cause differences in severity of
ischemic tissue injury. In CNG3, CNG4, and CNG5 Bc/Bc mice, whose collateral extents do
not differ from wildtype Bc (Figure 1C), infarct volume at 24 hours was not different from
wildtype Bc (Figure 2). By comparison, in CNG3, CNG4, and CNG5 B6/B6 mice, whose
collateral extents are rescued by 76, 91, and 82% (Figure 1C), infarct volume was
dramatically returned toward the low value of wildtype B6 (rescue of 85%). Furthermore,
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like collateral extent (Figure 1), rescue of infarct volume was intermediate in the
heterozygote condition. This congruency strongly strengthens the conclusion that the
difference in pial collateral extent is the major factor that determines the large difference in
infarct volume between Bc and B6 mice, and by inference, among 15 inbred mouse strains
examined previously.25 As with collateral number, the small residual difference in infarct
volumes between CNG3–5 B6/B6 and wildtype B6 may reflect the impact of the 3 other
small-effects QTL identified for collateral number in B6-x-Bc F2 mice.22
To test the hypothesis that the protective mechanism provided by the B6 allele of Dce1 is
collateral-dependent blood flow, we measured flow in the infarct zone of CNG4-B6/B6 and
CNG4–Bc/Bc 24 hours after MCAO using the microsphere method.33–35 Baseline blood
flow (non-ligated side) did not differ between strains (data not shown). Flow in the infarcted
region was 4.5-fold higher in B6/B6 mice (or 73% lower in Bc/Bc) (Figure 3). The higher
flow reduced but did not prevent some infarction. The latter is expected, given that
significant oxygen already diffuses from the ACA and PCA trees before traversing the
collaterals, and given that the estimated relative conductance of the native pial collateral
network in aggregate (including PCA↔MCA collaterals that typically number ~5 per
hemisphere in wildtype B6 mice and are larger in diameter) is 15–20 % of the conductance
of the trunk of the MCA tree at the site of ligation in wildtype Bc (Faber et al, unpublished).
We have shown that genetic strain-specific differences in collateral extent in brain are
shared in other tissues of the same mouse strains, including skeletal muscle.20,21 To
determine whether this extends to the Dce1 allele, we also examined skeletal muscle. Unlike
pial collaterals that can be measured with high fidelity, quantification of native collaterals in
the hindlimb that mostly reside deep in the adductor thigh where they cross-connect arterial
trees that branch in 3-dimensions, relies on the limited resolution of x-ray angiography20,21
or optical clearance of tissue followed by manual dissection.17 Therefore, we examined
collaterals in the sheet-like abdominal wall musculature of the mouse where, like in the pia,
the vascular trees are arranged in 2-dimensions. In agreement with the above findings in
brain, collateral number in CNG4-Bc/Bc did not differ from wildtype Bc, whereas the B6/
B6 alleles of Dce1 rescued collateral number to 54% of the 6-fold greater number in
wildtype B6 (Figure 4).
We next examined a model of PAD to test the hypothesis that the above finding extends to
the hindlimb and has functional significance. In support of this, blood flow determined
immediately after FAL and use and ischemic appearance scores measured one day later in
CNG4-Bc/Bc and CNG4-B6/B6 mice—values that are predominantly determined by native
collateral extent in the thigh—closely mimicked those previously reported in the wildtype
strains (Figure 5).20,21 That is, the B6/B6 allele of Dce1 strongly rescued blood flow
(perfusion was 73% greater than in CNG4-Bc/Bc immediately after FAL) and reduced/
rescued the severity of hindlimb ischemia and use impairment on day-1 (88 and 100%
reduction, respectively) (Figure 5C).
The improvement of blood flow that occurs over days-to-weeks after arterial occlusion
primarily reflects anatomic lumen enlargement of collaterals, a process distinct from the
process of collaterogenesis that occurs in the embryo/neonate.31,37 The latter, which is
governed largely by Candq1 in Bc and B6 mice, determines native collateral extent in the
adult and sets the baseline diameter upon which remodeling operates.21,31 We previously
found that Candq1 had no effect on variation in collateral remodeling in B6 and Bc mice,
apart from its effect on baseline collateral diameter and thus the shear stress stimulus that
drives collateral remodeling after arterial occlusion.18,22 Consistent with this, the increase in
hindlimb perfusion over day3–10 in CNG4-Bc/Bc was similar to wildtype Bc, while in
CNG4-B6/B6 it was 83% greater than CNG4-Bc/Bc (Figure 5B) and was ~55% of wildtype
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B6 (wildtype Bc and B6 values reported previously20,21). Similar data were obtained for
CNG5-B6/B6 (Online Figure II). In agreement with the above data, remodeling of pial
collaterals 3 days after MCAO was comparable in B6/B6 and Bc/Bc congenic mice to their
wildtype strains (Online Figure II). These data confirm previous findings that Candq1
(Dce1) does not link to the component of genetic-dependent variation in remodeling that is
independent of baseline diameter; a QTL for the latter was identified on chromosome 11.22
Genetic analysis of Dce1
We next analyzed Dce1 by evaluating published information available for the genes, single
nucleotide polymorphisms (SNPs), haplotypes, other genetic elements within Dce1, and by
evaluating knockout mice.
Gene analysis
Dce1 contains 28 protein-coding genes (Figure 1A and Online Table II). In contrast to the
previous candidate lists for Candq1 and coincident QTLs (see Introduction), in which no
gene had clear ties to vascular biology,19,24,25 seven genes in Dce1 can be at least
provisionally tied to endothelial cell (EC) biology (Rabep2, Sh2b1, Cln3, Apobr, Il27,
MapK3, and Ppp4c; Figure 6) (discussed below). We focused on ECs because
collaterogenesis occurs in the embryo by EC sprouting that involves VEGF-A, Flk1
(VEGFR2), Clic4 and Notch signaling,37,38,39 because collateral extent is altered in adult
mice with altered expression of eNOS,37 Dll4,40 connexin 4041,42 and synectin,43 and
because all of these genes are strongly expressed in ECs.
Two Dce1 genes listed above contain non-synonymous SNPs. The substitutions R298Q in
Rabep2 and H120Y in Cln3 are predicted to be “probably damaging” for protein function
(PolyPhen-2; scores > 0.999–1.0). Both proteins are intriguing since they are involved in
intracellular membrane trafficking, which is central to VEGF signaling.44–46 Ligated
VEGFR2 becomes phosphorylated and is internalized in complex with NRP-1 to early
endosomes under the control of Rab5. It then moves to Rab4 vesicles, the fast recycling
pathway, and then to Rab11, the slow recycling pathway. While internalized, the kinase
domain of VEGFR2 continues to signal downstream, notably to MapK3 (ERK1/2,
p44/42),47 and entry into the slow recycling pathway alters signaling.44 Rabep2
(Rabaptin-5beta) is a homolog of Rabep1 (Rabaptin-5), which in complex with Rabgef1
(Rabex-5) is an effector protein for Rab5 in the control of fusion of endocytic vesicles to
form the early endosome and for Rab4 in subsequent control of rapid endocytic
recycling.45,48 Rabep2 binds Rab5, Rab4 and Rabgef1, co-localizes with Rab5 on
endosomal membranes, and is necessary for full endosome fusion activity in vitro.45,48,49
The amino acids at position 298 in Rabep2 and the corresponding position (K578) in
Rabep1 are conserved among Rabep sequences. Replacement of K578 in Rabep1 by
glutamine is predicted to be only “possibly damaging” (score 0.694 by PolyPhen-2), but
there are no relevant experimental data on Rabep1 or 2. Interestingly, Rabep2 contains the
highest density of SNPs in Dce1 (Figure 6C, see below). We are currently generating mice
with disruption of Rabep2 since they have not been described.
Cln3, the gene responsible for juvenile Batten’s disease, codes an intracellular
transmembrane protein believed to be involved in late endosomal trafficking and lysosome
function.50–53 In mouse brain, Cln3 is expressed almost exclusively in ECs during the time
of collatergenesis (embryonic days E14.5-E18.537).29 We thus examined two different
Cln3−/− mice28,29 but observed no effect on collateral extent (Online Figure III).
The only other non-synonymous SNP in Dce1 is in the T-box transcription factor, Tbx6,54
giving the substitution Q331R, which is predicted to have no effect on protein function by
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Polyphen-2. This SNP and 3 others in Tbx6 also occur in one or more strains with high
collateral extent (CAST/EiJ, NOD/ShiLtJ),19 suggesting that Tbx6 is an unlikely candidate
gene (see SNP analysis, below). However, in a previous study, we determined relative
expression levels of 106 genes, including all 28 in Dce1, in the pia mater dissected from
brains of B6 and Bc embryos at 3 time-points spanning the time of collaterogenesis.19
Differential expression of Tbx6, Nfatc2ip and Slx1b achieved significance (Bc>B6) with
Tbx6 being the most strongly upregulated (2.9-fold). There are no reports of Tbx6 expression
in ECs cells or interaction with VEGF. However, Tbx6 has been shown to cooperate with
Notch intracellular domain in controlling expression of Hes7 and Mesp2.55–57 Thus, Tbx6
could be involved in vessel patterning58 and/or collaterogenesis.37 We are currently
generating mice with disruption of Tbx6 since they have not been described.
Nfatc2ip (Nip45) is a modulator of the type 2 T helper cell immune response in mice, with
the type 2 response being characteristic of Bc but not B6 mice. Nfatc2ip has a candidate
SNP in its 3’UTR (see below), which could explain the differential pial expression, although
Nfatc2ip mRNA is not recognized as an experimentally supported miRNA target (TARbase
v. 6.0).59 Slx1b is annotated as SLX1 structure-specific endonuclease subunit homolog B.
There are no reports of either Nfatc2ip or Slx1b in ECs. We are currently generating mice
with disruption of these genes, since they have not been described.
Jmjd5 (lysine-specific demethylase 8) was a particularly intriguing gene in the EMMA
region because of possible roles in transcriptional and epigenetic regulation, and a strong
argument was made for it as a candidate gene for Candq1.19 However, collateral extent in
mice globally haploinsufficient, globally hypomorphic, or with EC-specific knockout of in
Jmjd5 were not different from wildtype littermates (Online Figure IV).
Evidence that Sh2b1, Apobr, Il27, and Ppp4c are potential candidate genes is summarized in
the Online Supplement.
Dce1 is partially syntenic with human 16p11.2, a locus strongly implicated in
neurodegenerative disease, schizophrenia, autism, and severe early onset obesity.60–62
However, we found no reports of vascular disease associated with 16p11.2 or hits in GWAS
studies in 16p11 for vascular deficiencies.
SNP analysis
SNPs in Dce1 (Mouse Phenome database, Mouse Genomes Project) were evaluated in the
LookSeq pileups of deep sequencing data for Bc and B6 (see URLs in Online Table I). This
gave 72 high confidence SNPs. In a parsimonious model, a SNP responsible for low
collateral extent would be present in Bc and AKR/J, a low-collateral strain (averaging 4.8
pial collaterals)18 that is phylogenically identical to Bc in Dce1, but would not be present in
high collateral strains. Accordingly, we examined each SNP location in the high collateral
strains for which LookSeq data are available (LP/J, C3H/HeJ, CAST/EiJ, CBA/J, DBA/2J,
FVB/NJ, NOD/ShiLtJ, and129S1/SvimJ, plus A/J, a moderately low collateral strain (7
collaterals)18,19 This yielded 27 candidate SNPs (Online Table III) present in Bc and AKR
but not in the high collateral strains.
Five additional strains support the above SNP identifications. C57BLKS/J, 129X1/SvJ, and
KK/HiJ, are high collateral strains that have the B6 allele at each candidate SNP. SWR, the
strain having the lowest number of collaterals after Bc (2.6 collaterals),18 is phylogenically
identical to Bc in Dce1 and has the Bc allele at each candidate SNP. On the other hand, SJL
(high, at 19.2 collaterals) and NZW (medium, at 8.3) are also identical to Bc in Dce1. The
strong influence of Dce1 for determination of collateral extent can apparently be overridden
by loci elsewhere in the genome. These may include the loci on chromosomes 1, 3 and 8
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identified in B6-x-Bc F2 crosses,22 but a SJL-x-SWR-F2 failed to find any significant
QTL.19 Recently, Chu et al 63 applied a similar strategy to B6 and C3H/HeJ, which are
similar in collateral number but different in collateral diameter18 and cerebral infarct
volume,25 and identified a locus linked to infarct volume on chromosome 8 (Civq4) that is
coincident with Canq4.22 Mapping of number and diameter did not identify a significant
QTL on chromosome 8 in this cross (however, 50% fewer F2 mice were phenotyped for
collateral traits and those traits had 5-fold smaller ranges than infarct volume). The authors
concluded that Civq4 affects infarct volume in a collateral-independent manner.53 Such a
finding could have important ramifications. However, the conclusion remains uncertain
because, compared to B6 mice, C3H/HeJ have smaller collateral diameters, trend smaller in
number,18,63 and have lower blood pressure64 and hemoglobin content than
B6.65, Mouse Phenome Database These differences are relevant because oxygen delivery across a
collateral network after occlusion is proportional to [collateral number × diameter^4 ×
arterial pressure×arterial oxygen content]. Thus, even a “small” reduction in collateral extent
in the C3H/HeJ strain would result in a significantly greater infarct volume after MCAO.
Haplotype analysis
The genomes of the classical inbred mouse strains are assemblies of a blocks of DNA
(haplotypes) identical by descent from ancestral populations and recognizable by their
numbers and distributions of SNPs.66 Therefore, an alternative model is that the causal
element(s) in Dce1 lies in a haplotype, possibly enclosing collateral-influencing elements
that are linked or have interacting effects. Dce1 contains 3 haplotype blocks between B6 and
Bc (Figure 6A). These blocks contain 11 genes and 15 of the 27 candidate SNPs (Figure
6B). Of the 11 genes, only 2(Rabep2 and Sh2b1) can be linked through the literature to
possible roles in vascular biology.
The genes identified for relevance to vascular biology, proximity to candidate SNPs, and
location in Bc haplotype blocks are listed in Figure. 6B. The only gene present in all 3 lists
is Rabep2, in haplotype block 2, which contains 14 of the 27 candidate SNPs, 7 of which are
in Rabep2 (Figure 6C). These analyses thus converge on haplotype block 2, and suggest
Rabep2 in particular, as a possible causal element in Dce1.
Other genetic elements in Dce1
No conventional miRNAs were found in Dce1, but miRBase lists 2 “5p-tailed mirtrons”, or
miRNAs located in intronic sequences at splice junctions.67 Nothing is known of their
possible functions. NONCODE v.4 lists 51 long noncoding RNAs (≥ 2 exons, >200 base
pairs), including 24 long intervening RNAs (ie, between coding genes) and 27 that overlap
protein coding genes (reviewed in Ulitisky and Bartel).68 None of these appear to be
annotated regarding regulatory or small peptide coding functions or strain-differences in
expression. The longest of these transcribes exons 3–11 of Rabep2 and terminates at exons
14 and 15 of Atp2a1 (transcribed from the opposite strand), adding to the intrigue of
Rabep2. We also examined indels and structural and copy number variations in Bc versus
B6 in the Mouse Phenome Database. All 60 indels (Sanger2 data set in the Mouse Phenome
Database) were intergenic or intronic and usually located in highly repetitive sequences.
Three structural variations were small (240, 225 and 3 bases, Sanger3 data set) and located
intergenically or near the center of large introns. No copy number variations were listed
(Amgen1 data set). None of these elements were studied further.
DISCUSSION
The possibility that variation in the extent of the native collateral circulation is an important
determinant of variation in ischemic injury when acute arterial occlusion occurs or disease
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becomes manifest, has historically been overlooked or minimized—with the exception of
those who study or treat acute ischemic stroke, eg, 7–14 and refs therein some coronary
investigators,eg, 4–6,69 and refs therein and among vascular surgeons who frequently encounter
or perform arterial occlusions.70,71 This presumably extends, in part, from the small
diameter typical of native collaterals in most healthy individuals that is beyond the
resolution of digital angiography (>0.2 mm), the misconception that such minute vessels
cannot mediate significant flow in the acute setting until remodeling has occurred, and from
the inability to experimentally change native collateral extent to test its importance. The
latter restriction has begun to yield in recent studies where collateral extent was found to
vary widely in mice with differences in genetic background.18–22,31,72 This variation was
strongly correlated with differences in blood flow, tissue injury and functional impairment
after acute occlusion and in chronic recovery of flow and function during collateral
remodeling. However, whether these associations reflects a causal relationship could not be
determined because it was not been possible to change native collateral extent while keeping
genetic background constant. Even in inbred mice, including Bc and B6 strains, differences
in genetic background have significant effects on arterial pressure, microvascular regulation,
blood rheology, sensitivity of tissue to ischemia, immune response, inflammation,
expression of a many vascular-acting genes, and additional mechanisms that can each affect
collateral flow and tissue injury after acute and chronic arterial occlusion independent of
differences in native collateral extent (eg, see Mouse Phenome Database and Discussion/
references in 18–22,26,31,38, 64).
In the present study, we addressed this uncertainty by generating a congenic set of (CNG5,
currently backcrossed to effectively “N10”, see Results) with Dce1 allele-dose-dependent
differences in collateral extent that are essentially isogenic elsewhere in their genomes. We
show that congenic introgression of the Dce1 locus (737 Kb) of “high-collateral” B6 mice
into the genome of “low-collateral” Bc mice confers near-B6 levels of native collateral
number and diameter in the brain, as well as cerebral blood flow and infarct volume
following MCAO. Furthermore, we obtained similar effects for native collaterals in skeletal
muscle, as well as hindlimb blood flow, ischemic tissue appearance and use-impairment and
recovery of these parameters immediately after and on subsequent days following FAL. This
confirms previous studies20,21,38–40 showing that genetic effects on collateral extent apply to
multiple tissues for a given genetic background. The magnitude of the residual trait-
differences between congenic B6 strains and B6 wildtype mice agree with previous
estimates of the effect-size of three additional minor QTL for collateral number and/or
diameter.22 Thus, congenic substitution of a discrete locus strongly reduced the tissue injury
in models of stroke and PAD that occurs in a strain with poor collateral extent. These
findings demonstrate the importance of the native collateral circulation in determining the
severity of ischemic injury and capacity to recover blood flow and tissue function after
arterial occlusion. They also validate this same conclusion suggested in previous studies
examining different mouse strains.18–22 Thus, at least in the healthy young adult strains
examined thus far, genetic-dependent variation in native collateral extent strongly dominates
the above-mentioned collateral-independent factors in determining tissue injury.
Congenic introgression of the B6 allele of Dce1 into the Bc background rescued (“restored”)
collateral number to 85% of wildtype B6 in brain, but only 55% in skeletal muscle (Figures
1 and 4). This difference may reflect that muscle types differ greatly in arterial branch-
patterning and metabolic fiber type composition, ie, that the external and internal oblique
muscles and rectus abdominus, which compose the abdominal area that we studied, may not
be representative of all skeletal muscles viewed as a whole, with regard to collateral extent.
As stated in Results, we phenotyped this muscle area because, unlike other muscles but
much like the pial circulation, its arterial architecture is arranged in two dimensions and thus
can be imaged with high fidelity. The above difference could also reflect differences in the
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timing of collaterogenesis that may exist among different tissue types during development
and tissue growth, or differences in contribution of Dce1 to the extent of the native collateral
circulation. Regarding the latter, 3 additional small-effect QTL for collateral number were
identified in our earlier study.22 However, despite the difference in rescue shown herein,
these findings confirm previous work showing the dominance of the chromosome 7 locus,
now refined to Dce1, in determining the majority of the differences in collateral abundance
in multiple tissues of the mouse.18–22
Based on differential responses of skeletal muscle cells from B6 and Bc mice to hypoxia/
ischemia in vitro, it was recently proposed that besides controlling collaterogenesis, Candq1
also harbors a non-vascular, muscle cell-autonomous gene(s)—involved in plasticity and
survival of muscle precursor cells and expression of vascular factors and their cognate
receptors—that is important in the response to ischemia independent of differences in
collateral extent.26 This proposal, together with the fact that Civq1 for infarct volume after
MCAO is coincident with Candq1 and Lsq-1, thus suggests that the three QTL cover
multiple processes. If correct, the loci for these different processes should cease to overlap
during congenic dissection of Candq1. This should result in a retention of the trait-values for
(ie, rescue of) collateral extent and collateral-dependent perfusion, but a reduction in the
rescue of cerebral infarct volume after MCAO and hindlimb ischemic injury and use after
FAL, or a separation of the two processes in certain congenic strains. However, our findings
that congenic strains successively narrowing Candq1 from 27 Mb to 737 kb retain the same
values for all of these traits as the original interval, do not support this proposal.26
Notwithstanding the possibility that the above non-vascular process remains within this
narrow locus,63 the current findings strengthen the conclusion that Candq1, Civq1 and LSq-1
are QTLs for a single phenotype, collateral extent, and that the common causal element, ie,
one of the genetic elements presented in Results and Figure 6, lies in Dce1.
Identification of Dce1 adds a fourth list of candidate genes in the search for the genetic basis
of variation in collateral extent. The EMMA analysis of 21 strains,19 which confirmed our
F2 cross,18 came very close to pinpointing Dce1. It may have missed because of this limited
number of strains73 and possibly because of effects of strains A/J (very different from Bc at
Dce1 but with low collateral number) and SJL/J (identical to Bc at Dce1 but with high
collateral number). Similarly, the efforts to identify causal elements and candidate gene lists
in Civq125 and LSq-124 were deflected from Dce1 because they depended on the reasonable
assumption that causal elements would be identical between A/J and Bc, and distinct from
B6. This assumption was based on the findings that chromosome substitution strain 7, in
which B6 chromosome 7 is replaced by A/J chromosome 7, nearly phenocopies A/
J.21,22,24,25 However, the haplotype structure of A/J in Dce1 is quite distinct from those of
Bc and B6 (1513 and 1526 SNPs, respectively,Mouse Phenome Database) and none of the
candidate SNPs in Figure 6 is present in A/J. These findings, when combined with our
previous observation that collateral number and diameter were reduced by ~75% in B6 mice
whose chromosome 7 had been substituted with that of the A/J strain,21,22 suggest that a
different locus or one that interacts with Dce1 is present on chromosome 7 of A/J mice. An
obvious model which would reconcile these results and Dce1 would suppose an element on
chromosome 7, outside of Dce1 and identical in Bc and A/J, that favors high collateral
number if “activated” by a “signal” from an element in Dce1 having the B6 genotype. The
sequences of neither Bc nor A/J would be capable of such activation.
In conclusion, the results of this study provide strong evidence that genetic-dependent
variation in collateral extent underlies the three previously identified QTL, Candrq1, Civq1
and Lsq-1, and is the major physiological factor responsible for differences in ischemic
tissue injury in brain and hindlimb after arterial occlusion in B6, Bc and related19 mouse
strains. Our findings have also greatly narrowed the locus, denoted Dce1 (Determinant of
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collateral extent-1, 737 kb) and provided a gene list, refined by in silico analysis and use of
knockout mice, to guide future investigation. Although the causative genetic element(s) at
Dce1 has not yet been identified, we speculate it is a major “driver gene” or critical link in
the pathway that governs collaterogenesis, a process that occurs late during gestation and
determines collateral extent in the adult.37 Since the pathways governing angiogenesis
during development are highly conserved, polymorphisms of this same genetic element or a
related one in the signaling pathway controlling collaterogenesis may be important in the
wide variation in collateral status in humans,4–14 ie, may constitute a risk allele for collateral
insufficiency in brain and other tissues. This hypothesis, which is currently under
investigation in patients with acute ischemic stroke,74 is aided by the large effect-size of
Dce122,25 and the fact that the locus is contiguous on human chromosome 16. Lastly, we
have generated a congenic strain-set (CNG5) with wide “allele-dose-dependent” differences
in collateral extent. Since these mice are isogenic elsewhere in the genome, they provide a
unique strain-set for future investigations of the collateral circulation, including to model
patients with poor, intermediate and good collateral status.
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• In most tissues, adjacent arterial trees are connected by a small number of
arteriole-to-arteriole anastomoses termed collateral vessels that, in the event of
occlusion of an artery supplying one of the trees (eg, in stroke, myocardial
infarction or peripheral artery disease) can have a significant protective effect.
• Collateral-dependent blood flow varies widely among “healthy” humans, i.e.,
those without obstructive disease; however, the mechanisms responsible for this
variation are unknown.
• The number and diameters of collaterals vary widely among strains of inbred
mice, indicating that collateral extent is strongly influenced by genetic
background; a quantitative trait locus (QTL) on chromosome 7 has been linked
to the majority of this variation, but proof that this locus also causes the
variation in tissue injury among the strains has not been obtained.
What New Information Does This Article Contribute?
• Congenic mice have been generated in which successively smaller regions of
chromosome 7 of C57Bl/6J mice (B6; high collateral number and diameter) are
introgressed into the BALB/cByJ strain (Bc; very low collateral number and
diameter).
• The main genetic element determining variation in collateral extent in the
cerebral pial and skeletal muscle circulations in these congenic strains has been
localized to 737 kilobases (Dce1) on chromosome 7.
• Substitution of the B6 allele of Dce1 for the Bc allele imparts to Bc mice high
collateral extent and correspondingly greater tissue perfusion and protection in
models of stroke and peripheral artery disease, proving that genetic variation in
native collateral extent is the major determinant of variation in ischemic
damage.
Although no studies have been done, understanding the genetic determinants of the
extent of the native collateral circulation in humans could have significant impact in
assessing risk for severe ischemic outcomes and suggesting life style alterations prior to
ischemic events, assessing suitability and choice of recanalization treatment after an
event, and stratifying patients by genetically assessed risk in clinical trials. Previous work
in mice identified a major 27 Mb-wide QTL for variation in collateral extent on
chromosome 7. Others identified apparently identical QTLs for infarct volume in a stroke
model and tissue loss in a peripheral artery disease model. Efforts to identify the causal
elements in the QTL(s) relied on indirect analyses and inference to identify several
candidate genes, none of which are known angiogenic genes. The direct congenic
approach used here has sharply localized the causal region (Dce1) and suggested new
candidate genes, several of which are known to have vascular actions. The causal
relationship between collateral extent and tissue response in the congenic strains strongly
suggests that the three above QTLs all arise from a single phenomenon, collateral extent.
This study provides a new basis for identifying collateral genes and, potentially, for
assessing genetic influences on collateral extent in humans.
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Figure 1. Introgression of Dce1 into the Bc genome rescues collateral extent
A, Genetic maps of Candq1. Upper: input C57BL/6J × BALB/c recombinant inbred lines
CXB3 and CXB4.27 Black, genotype is B6; grey, Bc. Double-headed arrow: 95%
confidence interval of Candq1.22 Lower: Congenic strains showing B6 regions introgressed
into the Bc background. White indicates genotype uncertainty. The open rectangle indicates
the zone of overlap (133.229 – 133.966 Mb; Build 37 mm9 coordinates) common to all but
CNG1. The gene list in the overlap zone is not to scale. B, Filled pial pre-capillary vessels of
2–3 mos-old, maximally vasodilated CNG5 mice. Red stars: MCA-to-ACA collaterals.
Insets: Collateral zones at higher magnification. C, Average MCA↔ACA collateral
numbers (both hemispheres) and diameters in 2–3 mos-old wildtype B6 (black bar),
wildtype Bc (white) and CNG mice. Charcoal, introgressed region is B6/B6; light grey, Bc/
Bc; hatched, heterozygous. % rescue = (CNG-B6/B6 - wildtype B6) / wildtype B6 –
wildtype Bc). Within each genotype (B6/B6, B6/Bc, and Bc/Bc), CNGs 2–6 were
phenotypically indistinguishable in both number and diameter (ANOVA, 2-tailed), hence
the causal element(s) for both lie in the overlap zone (Dce1, Determinant of collateral extent
1). CNG1 mice of all 3 genotypes had phenotypes like Bc and were not studied further. In
all figures, numbers of mice are shown below or in each bar; for diameters in Bc/Bc mice,
n’s are low since many mice had no collaterals.
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Figure 2. Introgression of Dce1 into the Bc genome rescues cerebral infarct volume
Cortical infarctions were produced in 2–3 mos-old CNG3, CNG5 and wild-type mice by
permanent MCAO.16,18 24 hours later, brains were sectioned (1mm) and TTC-stained to
reveal non-viable tissue (white). Sections from the same brain level are shown. Infarct
volumes expressed as % of total brain volume were determined from the complete set of
sections in each brain. Within each genotype, CNG3, CNG4 and CNG5 are not significantly
different even though the introgressed regions in CNG3 and CNG4 extend beyond that in
CNG5 and include the EMMA peak (Figure 1A). This supports the conclusion that the
causal element for infarct volume, as for pial collateral number and diameter, lies in Dce1.
The B6/B6 genotype in CNG3, CNG4, and CNG5 rescues 85% of the difference between
wildtype B6 and Bc.
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Figure 3. Introgression of Dce1 into the Bc genome rescues blood flow after middle cerebral
artery occlusion (MCAO)
24 hr after permanent MCAO, relative blood flow in the volume of infarcted brain and
corresponding contralateral region (used for normalization) were determined using the
microsphere method after maximal dilation. Relative blood flow was 4.5-fold greater in
CNG4-B6/B6 compared to CNG4-Bc/Bc. Insets: Robust collateral-dependent retrograde
perfusion in CNG4-B6/B6 is indicated by minimal brown clotted blood in the MCA
territory, compared to the clearly visible brown tracks in the CNG-Bc/Bc brain. Baseline
flow (non-ligated side) did not differ between strains.
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Figure 4. Introgression of Dce1 into the Bc genome rescues collateral number in skeletal muscle
Pre-capillary microcirculation in maximally dilated CNG4 and wildtype mice were filled
with MicroFil. After fixation and optical clearing, collaterals between the epigastric and
iliolumbar arteries, viewed from the peritoneal surface, were counted (red stars). Insets:
collateral zones at higher magnification. The homozygous B6 Dce1 allele restores 54% of
the difference in collateral number between Bc and B6 wildtype mice.
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Figure 5. Introgression of Dce1 into the Bc genome rescues hindlimb perfusion following femoral
artery ligation (FAL)
A, Laser Doppler perfusion images of plantar region-of-interest (dotted line; quantified in
panel B) before and after FAL. B, 73% greater perfusion immediately after FAL in B6/B6 is
in agreement with greater native collateral extent in skeletal muscle (Figure 4); larger
deviation at day-3 and day-10 is consistent with outward remodeling of a greater number of
collaterals. Recovery of perfusion at day-10 was 83% greater in B6/B6. C, Severity of
hindlimb use-impairment and ischemic appearance were reduced/rescued on day-1 by 88
and 100%, respectively, and were less severe thereafter.
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Figure 6. Haplotype, gene and SNP distribution in Dce1
A, Haplotype maps of B6 and Bc in Dce1 from the Mouse Phylogeny Viewer.66 Three
haplotype blocks contain 11 of the 28 genes and 15 of the 27 candidate SNPs in Dce1 that
distinguish Bc from B6. B, Genes within Dce1 that are involved in vascular biology, harbor
candidate SNPs, or occur in haplotype blocks. Rabep2, the only gene in all 3 categories,
contains 7 candidate SNPs (5 intronic, one synonymous, one non-synonymous) and lies in
the small haplotype block number 2 (73 kb) in which lie half of the candidate SNPs in Dce1.
Numbers in parentheses indicate the number of candidate SNPs in each block. C, All SNPs
(red bars) and candidate SNPs (black) are unevenly distributed in Dce1.
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